Structural Rearrangements in DNA Repair Genes in Breast Cancer

Abstract

The genetic basis of cancer has been firmly established in the last few decades. Genomic instability is a hallmark feature of virtually all breast cancer cells, and is caused either by inherited mutations in genes that control genomic fidelity and stability (particularly in DNA repair pathways), or somatic mutations that are acquired during breast cancer progression. We originally identified translocations in 3 DNA repair genes (RAD51C, EYA2, BRIP1) in MCF7 breast cancer cells, and hypothesized that structural genomic alterations in genes that are themselves actually involved in DNA repair enhance the level of genomic instability and ultimately affect breast cancer progression and prognosis. However, we found that these translocations are specific to MCF7 cells (private mutations) and not present in any other cell lines. Interestingly, we found that BRIP1, a known familial tumor suppressor is amplified in a large portion of sporadic breast cancers. In cells with amplification of BRIP1, knockdown of BRIP1 inhibited cell growth suggesting that BRIP1 might be a driver of breast cancer growth. Mass-spec analysis identified a novel role for BRIP1 as a transcriptional repressor. This study has thus identified a familial tumor suppressor gene which is amplified in sporadic breast cancer and has a novel transcriptional regulatory role.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2013
Accession Number
ADA592383

Entities

People

  • Adrian V Lee

Organizations

  • University of Pittsburgh

Tags

DTIC Thesaurus Topics

  • Amplification
  • Biomedical Research
  • Breast Cancer
  • Cell Line
  • Cells
  • Gel Electrophoresis
  • Gene Expression
  • Genomic Instability
  • Instability
  • Mass Spectrometry
  • Neoplasms
  • Proteins
  • Reliability
  • Suppressors
  • Transcription Factors
  • Tumor Cell Line

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology